Mapping the proteo-genomic convergence of human diseases

We performed genome-proteome-wide association analysis for 4,775 human plasma proteins assayed by the SomaScan v4 platform among over 10,000 individuals, identifying 2,584 genomic regions associated with at least one out of 3,892 protein targets. Explore our results here.


Image generated using BioRender.

Cross-platform genetic discovery of metabolism products

In our cross-platform, genome-wide meta-analyses of 174 blood metabolites across six cohorts and including over 80,000 participants we identified 362 genome-wide significant associations and provide examples of the influence of metabolite-associated variants on human health. Summary statistics (meta-analyses and individual studies) are available here.

Shared and distinct metabolite profiles of incident diseases

Investigating the association of 1,014 blood metabolites with 27 incident diseases, all-cause mortality and disease multimorbidity in more than 11,000 participants, we identified shared and distinct pathways to non-communicable diseases and multimorbidity. We provide a comprehensive catalogue of risk factor - metabolite - disease associations by integrating data from over 50 modifiable clinical and other risk factors. Explore our results here.

Genetic architecture of host proteins interacting with SARS-CoV-2

We integrated genomic and proteomic data from over 10,000 individuals to characterize the genetic architecture of host proteins reported to interact with SARS-CoV-2 or to be related to virus entry, the host hyper-immune or procoagulant response, or severity of COVID-19. Explore our results here.